Equities
Health CarePharmaceuticals and Biotechnology
  • Price (CHF)39.91
  • Today's Change-0.265 / -0.66%
  • Shares traded66.62k
  • 1 Year change+50.66%
  • Beta--
Data delayed at least 20 minutes, as of Nov 14 2024 16:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income80850910
Depreciation/depletion251235261
Non-Cash items919427524
Cash taxes paid, supplemental245273485
Cash interest paid, supplemental1608062
Changes in working capital(1162)(546)(605)
Total cash from operations3621,2231,354
INVESTING
Capital expenditures(625)(427)(416)
Other investing and cash flow items, total11(3)(275)
Total cash from investing(614)(430)(691)
FINANCING
Financing cash flow items(2659)(791)(653)
Total cash dividends paid------
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net3,90122(4)
Total cash from financing1,242(769)(657)
NET CHANGE IN CASH
Foreign exchange effects4510.00(5)
Net change in cash1,035341.00
Net cash-begin balance/reserved for future use744039
Net cash-end balance/reserved for future use1,1097440
SUPPLEMENTAL INCOME
Depreciation, supplemental251235261
Cash interest paid, supplemental1608062
Cash taxes paid, supplemental245273485
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.